Disorders of glossopharyngeal nerve

G6_DISGLO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G52.1
  • Hospital discharge: ICD-9 3521
  • Hospital discharge: ICD-8 35602
  • Cause of death: ICD-10 G52.1
  • Cause of death: ICD-9 3521
  • Cause of death: ICD-8 35602

2 out of 7 registries used, show all original rules.

65

4. Check minimum number of events

None

65

5. Include endpoints

None

65

6. Filter based on genotype QC (FinnGen only)

65

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G52
Name in latin
Morbositates nervi glossopharyngei

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 479 287 186
Only index persons 424 266 158
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 54.76 53.17 56.97
Only index persons 53.35 52.25 55.20

-FinnGen-

Key figures

All Female Male
Number of individuals 65 39 26
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 54.55 53.63 55.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
59
Matched controls
591
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G52.1
ICD-10 Finland
Disorders of glossopharyngeal nerve
+∞
72.8
54
*
N03AF01
ATC
carbamazepine; oral, rectal
27.8
18.2
25
15
G50.0
ICD-10 Finland
Trigeminal neuralgia
+∞
10.7
10
*
N03AX16
ATC
pregabalin; oral
6.1
8.6
27
71
G50.1
ICD-10 Finland
Atypical facial pain
+∞
8.5
8
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022145) Colonoscopy Study observation
15
58
3.06
3.14
1.2
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
5
10.67
3.03
1.0
1.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
7
15
5.09
2.67
1.0
1.8
ug/l
0.3
0.5
—
7
15
(3045414) Leukocytes [Presence] in Urine
8
20
4.41
2.66
1.8
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
13
4.96
2.33
1.0
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
35
235
2.06
2.12
12.3
6.4
mmol/l
1.2
1.2
0.88
30
213
(4094501)
6
15
4.29
2.09
1.2
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
20
113
2.11
1.88
3.5
1.9
mg/l
1.0
1.4
0.37
15
96
(3025941) Bacteria identified in Stool by Culture
8
31
2.80
1.72
1.8
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.77
1.64
1.4
2.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
14
3.77
1.64
1.0
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
33
2.62
1.60
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
36
263
1.83
1.55
11.5
6.9
mmol/l
1.2
1.2
1.14
29
216
(3019225) pH of Specimen
9
40
2.45
1.47
4.9
4.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
45
356
1.86
1.46
7.3
4.6
—
7348.4
—
0
8
(40761535) Cells panel - Urine sediment
9
41
2.38
1.44
2.3
3.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
29
206
1.74
1.32
2.4
1.9
pmol/l
81.1
88.6
0.63
13
91
(3023368) Bacteria identified in Blood by Culture
20
130
1.78
1.21
3.8
4.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
19
122
1.79
1.20
3.1
2.4
—
—
—
0
0
(3015736) pH of Urine
30
221
1.66
1.16
3.5
3.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
5
21
2.49
1.11
3.2
3.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
29
215
1.63
1.08
10.4
7.6
inr
1.3
1.2
—
5
64
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
22
2.37
1.05
1.0
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
7
35
2.12
1.03
36.0
13.3
%
96.1
94.7
—
7
35
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
7
37
2.00
0.97
1.3
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
23
165
1.61
0.96
8.4
5.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
28
2.26
0.94
1.3
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
30
2.10
0.89
2.7
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
18
124
1.62
0.87
4.1
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
23
169
1.56
0.86
3.9
3.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
16
110
1.60
0.78
1.6
1.7
nmol/l
910.5
1280.9
—
10
78
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
16
111
1.59
0.75
2.1
1.6
pmol/l
442.6
466.6
0.16
11
91
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
93
0.50
0.73
4.0
2.8
mmol/l
0.9
0.8
—
5
87
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
26
2.00
0.72
1.4
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
44
1.66
0.67
2.9
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
29
1.78
0.65
1.2
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
19
142
1.48
0.64
2.7
3.0
mg/l
6603.9
40.4
0.77
12
91
(3002173) Hemoglobin [Mass/volume] in Arterial blood
8
52
1.61
0.62
32.6
10.7
g/l
108.8
122.3
—
8
52
(3049717) Cytology report of Urine Cyto stain
0
19
0.00
0.61
0.0
2.9
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
73
1.61
0.61
3.3
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
6
35
1.79
0.59
36.3
9.7
mmol/l
26.2
26.1
—
6
35
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
82
1.57
0.59
1.3
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
6
36
1.73
0.58
5.8
5.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
21
163
1.43
0.58
2.9
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
6
37
1.68
0.57
1.2
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
38
1.64
0.56
3.0
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
75
1.56
0.55
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
9
64
1.47
0.54
28.7
9.4
mmol/l
1.8
1.8
—
9
53
(3019150) Specific gravity of Urine by Refractometry
15
112
1.44
0.50
4.2
4.0
—
1.0
—
0
8
(40768804) Tissue Pathology biopsy report
27
225
1.34
0.48
1.9
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
55
512
1.48
0.46
4.8
4.6
mmol/l
1.5
1.5
0.06
50
462
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
34
295
1.32
0.46
3.4
2.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
8
59
1.41
0.43
1.6
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
35
307
1.30
0.43
7.7
9.4
e9/l
3.6
4.1
0.60
27
265
(3002256) Pathology report gross observation
8
60
1.38
0.42
1.4
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
10
71
1.48
0.42
9.0
8.2
—
—
—
0
0
(3044889) 12 lead EKG panel
42
378
1.31
0.42
4.4
4.0
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
17
0.00
0.41
0.0
2.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
9
66
1.42
0.41
1.2
1.4
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
30
261
1.28
0.38
6.8
5.9
e9/l
0.2
0.2
0.46
23
225
(3037467) Urinalysis macro (dipstick) panel - Urine
39
351
1.28
0.37
7.7
4.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
29
252
1.27
0.37
6.7
5.8
e9/l
0.5
0.6
0.37
23
219
(3000991) Gas panel - Venous blood
6
43
1.43
0.36
39.3
11.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
18
147
1.31
0.36
2.5
3.0
mmol/l
6.9
6.8
0.02
12
123
(3006315) Basophils [#/volume] in Blood
29
253
1.26
0.35
6.7
5.8
e9/l
0.0
0.0
0.27
23
219
(3003694) ABO and Rh group [Type] in Blood
11
141
0.74
0.34
1.9
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
23
197
1.26
0.32
3.4
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10
129
0.73
0.32
5.5
4.5
%
18.8
22.8
—
5
63
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
7
54
1.33
0.31
1.7
2.6
umol/l
4.9
7.5
—
7
48
(3041096) Erythrocytes [Presence] in Urine by Automated
13
160
0.77
0.30
3.8
3.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
29
257
1.23
0.30
7.3
5.8
e9/l
1.6
2.0
0.69
23
224
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
74
1.25
0.27
1.4
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
21
182
1.23
0.26
2.3
3.0
mmol/l
2.3
2.4
0.27
16
161
(3023103) Potassium [Moles/volume] in Serum or Plasma
57
546
1.36
0.23
27.1
16.2
mmol/l
4.0
4.0
0.01
57
530
(40758558) Short blood count panel - Blood
10
123
0.78
0.23
4.9
7.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
27
243
1.19
0.22
7.6
9.3
e9/l
0.0
0.0
0.71
21
200
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
9
111
0.78
0.22
1.6
2.7
mmol/l
2.4
2.5
—
9
100
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
42
1.21
0.22
1.0
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
4.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
4.2
—
3.9
—
0
12
(3035285) Chloride [Moles/volume] in Venous blood
0
12
0.00
0.21
0.0
4.2
—
105.6
—
0
12
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
79.3
—
0
14
(3018095) Leukocytes [#/volume] in Urine
22
196
1.19
0.20
4.3
3.6
e6/l
3.4
97.2
1.24
11
146
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
66
0.74
0.18
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8
69
1.18
0.17
1.5
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
9
80
1.14
0.16
3.0
1.8
umol/l
9.9
13.1
—
9
74
(3020564) Creatinine [Moles/volume] in Serum or Plasma
57
554
1.23
0.15
24.7
16.7
umol/l
75.4
77.6
0.37
57
554
(3002385) Erythrocyte distribution width [Ratio]
42
440
0.87
0.15
20.5
17.5
%
13.8
13.9
0.28
42
429
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
55
534
1.19
0.13
22.7
13.9
mg/l
24.8
22.7
0.17
47
412
(3020682) Albumin/Creatinine [Ratio] in Urine
17
155
1.13
0.10
2.8
3.9
mg/mmol
2.5
6.0
—
8
98
(3005719) IgG [Mass/volume] in Serum or Plasma
5
43
1.18
0.10
1.6
2.4
g/l
10.0
10.6
—
5
38
(3002582) Erythrocytes [#/volume] in Urine
16
175
0.89
0.10
3.3
3.0
e6/l
4.1
42.6
—
10
133
(3021447) Carbon dioxide [Partial pressure] in Venous blood
6
53
1.15
0.09
6.0
3.9
kpa
6.2
5.7
—
6
53
(3012544) pH of Venous blood
6
53
1.15
0.09
6.0
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
123
0.87
0.09
6.3
4.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
18
194
0.90
0.08
2.6
3.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
7
63
1.12
0.08
1.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
64
1.10
0.08
1.7
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
58
584
0.94
0.08
31.2
20.5
pg
30.4
30.4
0.10
58
574
(3026361) Erythrocytes [#/volume] in Blood
58
584
0.94
0.08
31.6
20.5
e12/l
4.3
4.5
0.69
58
565
(3007461) Platelets [#/volume] in Blood
58
584
0.94
0.08
31.6
20.6
e9/l
254.5
246.0
0.59
58
568
(3024731) MCV [Entitic volume]
58
584
0.94
0.08
31.3
20.5
fl
91.5
91.3
0.10
58
574
(3010813) Leukocytes [#/volume] in Blood
58
584
0.94
0.08
31.5
20.6
e9/l
7.0
6.7
0.17
58
564
(3000963) Hemoglobin [Mass/volume] in Blood
58
584
0.94
0.08
31.6
20.7
g/l
131.8
134.7
0.75
58
574
(36304419) Bacteria [Presence] in Urine
17
157
1.11
0.08
3.5
2.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
9
87
1.04
0.07
3.2
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
57
556
1.20
0.07
17.8
13.2
—
—
—
0
0
(3013512) EKG study
15
162
0.90
0.07
5.1
4.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
17
162
1.07
0.02
3.3
2.8
e6/l
0.0
0.4
2.51
11
119
(3009542) Hematocrit [Volume Fraction] of Blood
46
466
0.96
0.00
24.8
15.2
%
38.4
39.1
0.20
33
327
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
16
156
1.03
0.00
7.2
4.9
ug/l
1.3
2.7
1.18
11
136
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
25
254
0.97
0.00
4.8
4.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
50
1.00
0.00
2.6
3.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.0
—
25.8
—
0
8
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
329.4
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
7.0
—
0
5
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
4.2
—
0
8
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
5
0.00
0.00
0.0
1.0
—
12.8
—
0
5
(3028433) Virus identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
2.0
—
238.9
—
0
8
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
1.9
—
0
5
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
7
74
0.94
0.00
3.0
1.8
g/l
2.5
2.3
—
7
69
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
13.3
—
0
5
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
1.2
1.7
g/l
0.2
0.2
—
5
46
(40768797) Stomach Pathology biopsy report
7
71
0.98
0.00
1.0
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
7
70
1.00
0.00
2.9
1.9
%
14.9
21.0
—
7
65
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
8.6
—
0
5
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
22
220
1.00
0.00
4.4
4.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
7
0.00
0.00
0.0
1.6
—
31.9
—
0
7
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
0
5
0.00
0.00
0.0
3.0
—
3.5
—
0
5
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
3.0
—
27.4
—
0
8
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_DISGLO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_DISGLO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_DISGLO – Disorders of glossopharyngeal nerve

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data